Plasminogen - safe for treatment of chronic tympanic membrane perforation: a phase 1 randomized, placebo-controlled study

Elnaz Sepehri Bo Tideholm Sten Hellström Cecilia Engmér Berglin a Division of Ear,Nose and Throat Diseases,Department of Clinical Sciences,Intervention and Technology,Karolinska Institutet,Stockholm,Swedenb Division of Ear,Nose and Throat Diseases,Hearing and Balance,Karolinska University Hospital,Stockholm,Sweden
DOI: https://doi.org/10.1080/00016489.2024.2396488
IF: 1.698
2024-09-13
Acta Oto-Laryngologica
Abstract:Background There is a need for a simpler and accessible intervention to heal tympanic membrane perforations than myringoplasty that is todaýs golden standard. Experimental studies have identified plasminogen as a promising agent for medical treatment of chronic tympanic membrane perforation.
otorhinolaryngology
What problem does this paper attempt to address?